Filing Details
- Accession Number:
- 0001171843-16-010511
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-06 17:03:23
- Reporting Period:
- 2016-06-02
- Filing Date:
- 2016-06-06
- Accepted Time:
- 2016-06-06 17:03:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1467848 | Brian Tambi | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-02 | 25,000 | $2.61 | 58,591 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-06-02 | 25,000 | $6.62 | 83,591 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-02 | 25,000 | $30.73 | 58,591 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2016-06-02 | 25,000 | $0.00 | 25,000 | $2.61 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2016-06-02 | 25,000 | $0.00 | 25,000 | $6.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-21 | No | 4 | M | Direct | |
| 0 | 2011-04-29 | No | 4 | M | Direct |
Footnotes
- Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $30.66 to $30.83 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Amount of Shares Beneficially Owned Following Reported Transaction includes 6,026 unvested shares subject to restricted stock awards and 52,565 shares owned outright.
- These options were fully vested and scheduled to expire if not exercised on or before May 21, 2015. However, due to legal restrictions under the securities laws, the options could not be exercised until June 2, 2016 and thus the expiration date was tolled until July 2, 2016.
- These options were fully vested and scheduled to expire if not exercised on or before April 29, 2016. However, due to legal restrictions under the securities laws, the options could not be exercised until June 2, 2016 and thus the expiration date was tolled until July 2, 2016.
Billionaire Hedge Funds
